Morning Brief – 19-Apr-2018

0
1308
Morning Brief Images 19-Apr-2018

UK Stock Market News Today – 19-Apr-2018

Morning all!

A few PC issues this morning – What’s the issue with the Surface Pro 4 sometimes just refusing to ignore the 2 connected monitors even after many restarts! Anyway…

Debenhams (DEB) – 23.32p – £276.3m – PER 6.07

Interim Results For The 26 Weeks To 3 March 2018 – LFL Revenue down 2.2% (CC) and most other stuff down 50% or so, including the Dividend.

I said this last time and I still have the same feeling – I just have no idea where Debenhams will be in 5 (or even 2) years time – Will it be bust or soaring high once again? Or, still struggling along? I favour the struggling along or bust options – I am Avoiding for now.

Gattaca (GATC) – 193p – £57.7m – PER 5.19

Interim Results For The 6 Months To End January 2018 – Growth but not much of it, Dividend cut 50%. February and March broadly in-line but (Ouch!) expects FY PBT to be about 15% belowprevious expectations.

I remain Neutral for now.

Idox (IDOX) – 30.45p – £127.4m – PER 8.33

Trading Update For The 5 Months To End April 2018 – H1 expected to be well below the same period last year but confident of FY in-line with expectations – Yeah right!

I will not be getting involved here at present.

Science (SAG) – 204p – £81.6m – PER 13.6

Business Update – 2018 Q1 Revenue and Profits ahead of the Board’s expectations. Buy Back program, up to £100,000 per calendar month capped at £1m annually.

Quite like this but just not yet tempted enough, will keep an eye out for updates.

Trifast (TRI) – 269p – £326.5m – PER 19.6

Trading Update For The 12 Months To End March 2018 – Underlying PBT to be slightly ahead of managements expectations. Order pipeline encouraging, enters the new year in a confident mood.

A great 5 year return here for investors and this update is encouraging too. I remain Neutral for now, perhaps worth a look on a pullback to the 250p level if we see it.

MPAC (MPAC) – 224p – £45.2m – PER 19.6

AGM Statement And Board Change – Q1 ahead of last year and in-line – CEO is stepping down, replacement confirmed.

Probably fairly priced for me, I’m Neutral.

Rhythm One (RTHM) – 178p – £138.0m – PER 4.80

Trading Update For The 12 Months To End March 2018 – Revenue growth is excellent (71%) and Adjusted EBITDA is up 900%.

Impressive update but I will wait to see the actual results (and what the real profits are). Neutral for now.

Due to tech issues, was a real rush so do please correct me as appropriate.

And, as always, all comment most welcome – Have a great day!

Advertisement
Research Tree Banner